Aytu Biopharma Inc (AYTU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 30,732 | 22,733 | 26,279 | 27,655 | 27,448 |
| Cost of Goods | 12,168 | 9,990 | 8,986 | 9,623 | 12,606 |
| Gross Profit | 18,564 | 12,743 | 17,293 | 18,032 | 14,842 |
| Operating Expenses | 18,563 | 22,291 | 25,147 | 20,463 | 32,940 |
| Operating Income | 169 | -8,558 | -6,868 | -1,808 | -17,492 |
| Other Income | -2,626 | 1,358 | 175 | 1,107 | 1,403 |
| Pre-tax Income | -2,457 | -7,200 | -6,693 | -701 | -16,089 |
| Net Income Continuous | -2,457 | -7,200 | -6,693 | -701 | -16,089 |
| Net Income | $-2,457 | $-7,200 | $-6,693 | $-701 | $-16,089 |
| EPS Basic Total Ops | -0.75 | -1.93 | -2.15 | -0.28 | -7.61 |
| EPS Basic Continuous Ops | -0.74 | -1.93 | -2.15 | -0.28 | -7.59 |
| EPS Diluted Total Ops | -0.75 | -1.93 | -2.15 | -0.28 | -7.61 |
| EPS Diluted Continuous Ops | -0.74 | -1.93 | -2.15 | -0.28 | -7.59 |
| EPS Diluted Before Non-Recurring Items | 0.16 | -1.93 | -1.31 | N/A | N/A |
| EBITDA(a) | $2,431 | $-8,868 | $-1,892 | $638 | $-4,321 |